Home
Conditions
Bronchial Neoplasms

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,255 public trials 1,184 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

NCT07086300

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

NCT06579196

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Recruiting

Copenhagen Master Observational Trial

NCT05145244

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Recruiting

A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC

NCT06951464

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases

NCT07008287

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC

NCT04136535

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Caner hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Uninon Medical college Shenzhen, shenzhen, China

View Trial Details

Recruiting

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

NCT06709859

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Shandong Public Health Clinical Center Jinan, Shangdong, China

View Trial Details

Recruiting

Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer

NCT07070011

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +8 more
Locations: Shanghai Chest Hospital Shanghai, China

View Trial Details

Recruiting

A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

NCT06962865

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Beijing Chest Hospital,Capital Medical Unniversity Beijing, China

The Fifth Medical Center of Chinese People's Liberation Army General Hospital Beijing, China

Binzhou Medical University Hospital Binzhou, China

Jilin Cancer Hospital Changchun, China

View all 34 locations

View Trial Details

Recruiting

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

NCT06167460

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Medical Genetics Institute Ho Chi Minh City, Vietnam

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Related conditions